Target intelligence / Profile preview

Ribosomal protein L13a pseudogene

Molecular classification: Other (Pseudogene)

Overview

Ribosomal protein L13a pseudogenes are non-functional genomic sequences derived from the functional ribosomal protein L13a (RPL13A) gene[5][6][1]. These pseudogenes do not encode functional proteins and generally have no known biological or therapeutic role. Like other pseudogenes, they may occasionally be transcribed, but do not give rise to active ribosomal proteins. The canonical, protein-coding version of this family is ribosomal protein L13a (RPL13A), found under Ensembl gene ID ENSG00000142541[2][3][8]. The pseudogene ENSG00000226987 is not considered a valid drug target, receptor, enzyme, transporter, or transcription factor.

Other names: RPL13APRPL13AP[numerals]ribosomal protein L13a pseudogene 13

Beyond the preview

Go deeper on Ribosomal protein L13a pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L13a pseudogene.

Explore the full profile